Compare $LNAI vs $XBIO | Chartloom

Compare

$LNAI vs $XBIO

Lunai Bioworks Inc · Xenetic Biosciences Inc

LNAI

Lunai Bioworks Inc

XBIO

Xenetic Biosciences Inc

Compare $LNAI vs $XBIO

Comparing Lunai Bioworks Inc and Xenetic Biosciences Inc

LNAILunai Bioworks Inc

XBIOXenetic Biosciences Inc

LNAILunai Bioworks Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.2%

52W performance

-87.6%

FCF yield

-94.4%

XBIOXenetic Biosciences Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

33.3%

YTD performance

-0.9%

52W performance

-79.4%

FCF yield

-47.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LNAI

XBIO

Detailed metrics comparison

LNAI

Lunai Bioworks Inc

XBIO

Xenetic Biosciences Inc

Market Cap

LNAI$6M

XBIO$5M

Enterprise Value

LNAI$3M

XBIO$-2M

Price

LNAI$1.23

XBIO$2.13

P/E Ratio

LNAIN/A

XBION/A

P/S Ratio

LNAI266.60x

XBIO1.50x

EV/Sales

LNAI163.08x

XBIO-0.49x

EV/EBITDA

LNAI0.00x

XBIO0.00x

P/B Ratio

LNAI0.07x

XBIO0.81x

P/FCF Ratio

LNAIN/A

XBION/A

EV/FCF

LNAI-0.65x

XBIO0.69x

PEG Ratio

LNAIN/A

XBION/A

Forward P/E (NTM)

LNAIN/A

XBION/A

Forward P/S (NTM)

LNAIN/A

XBION/A

Revenue (TTM)

LNAI$21K

XBIO$3M

Revenue Growth (YoY)

LNAIN/A

XBIO33.3%

Forward Rev Growth

LNAI0.0%

XBIO-16.7%

Gross Margin (TTM)

LNAI0.0%

XBIO98.7%

Operating Margin (TTM)

LNAI0.0%

XBIO0.0%

EBITDA Margin (TTM)

LNAI-46584.2%

XBIO-81.0%

Net Margin (TTM)

LNAI-613799.0%

XBIO-75.9%

FCF Margin (TTM)

LNAI-25165.1%

XBIO-70.9%

Net Income (TTM)

LNAI$-128M

XBIO$-2M

FCF (TTM)

LNAI$-5M

XBIO$-2M

EPS (TTM)

LNAI-$41.06

XBIO-$1.08

ROE (TTM)

LNAI-6700.0%

XBIO-4062.0%

ROA (TTM)

LNAI-161778.0%

XBIO-3497.0%

ROIC (TTM)

LNAI-6439.0%

XBIO-4062.0%

Cash

LNAI$3M

XBIO$6M

Debt

LNAI$992K

XBIO$0

Net Cash/Debt

LNAI$2M

XBIO$6M

Current Ratio (TTM)

LNAI0.19x

XBIO7.43x

Quick Ratio (TTM)

LNAI0.16x

XBIO7.23x

Debt/Equity (TTM)

LNAI0.07x

XBIO0.00x

Debt/Assets (TTM)

LNAI0.0%

XBIO0.0%

Interest Coverage (TTM)

LNAIN/A

XBION/A

Net Debt/EBITDA (TTM)

LNAI0.00x

XBIO0.00x

Beta

LNAI0.32

XBIO2.36

52W Performance

LNAI-87.6%

XBIO-79.4%

YTD Performance

LNAI-84.2%

XBIO-0.9%

% from 52W High

LNAI-90.7%

XBIO-79.2%

% from 52W Low

LNAI40.5%

XBIO13.9%

Asset Turnover (TTM)

LNAI0.00x

XBIO0.46x

FCF Yield (TTM)

LNAI-94.4%

XBIO-47.4%

Earnings Yield (TTM)

LNAI-2302.3%

XBIO-50.7%

Dividend Yield (TTM)

LNAIN/A

XBION/A

Rule of 40

LNAI-25,165.1

XBIO-37.6

EV/GP/RG

LNAIN/A

XBION/A

Ticker research

View LNAI research View XBIO research

Metric	LNAI Lunai Bioworks Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$6M	$5M
Enterprise Value	$3M	$-2M
Price	$1.23	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	266.60x	1.50x
EV/Sales	163.08x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.07x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$21K	$3M
Revenue Growth (YoY)	N/A	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	0.0%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-46584.2%	-81.0%
Net Margin (TTM)	-613799.0%	-75.9%
FCF Margin (TTM)	-25165.1%	-70.9%
Net Income (TTM)	$-128M	$-2M
FCF (TTM)	$-5M	$-2M
EPS (TTM)	-$41.06	-$1.08
ROE (TTM)	-6700.0%	-4062.0%
ROA (TTM)	-161778.0%	-3497.0%
ROIC (TTM)	-6439.0%	-4062.0%
Financial Health
Cash	$3M	$6M
Debt	$992K	$0
Net Cash/Debt	$2M	$6M
Current Ratio (TTM)	0.19x	7.43x
Quick Ratio (TTM)	0.16x	7.23x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.32	2.36
52W Performance	-87.6%	-79.4%
YTD Performance	-84.2%	-0.9%
% from 52W High	-90.7%	-79.2%
% from 52W Low	40.5%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-94.4%	-47.4%
Earnings Yield (TTM)	-2302.3%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-25,165.1	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View LNAI research	View XBIO research

Valuation

P/S Ratio

XBIO

1.50x

LNAI

266.60x

EV/FCF

LNAI

-0.65x

XBIO

0.69x

Growth & revenue

Revenue Growth TTM

XBIO

33.3%

Forward Revenue Growth

LNAI

0.0%

XBIO

-16.7%

Profitability & performance

Gross Margin

XBIO

98.7%

LNAI

0.0%

ROE

XBIO

-4062.0%

LNAI

-6700.0%

FCF Yield %

XBIO

-47.4%

LNAI

-94.4%

52-Week Performance

XBIO

-79.4%

LNAI

-87.6%

Detailed metrics comparison

LNAI

Lunai Bioworks Inc

XBIO

Xenetic Biosciences Inc

Market Cap

LNAI$6M

XBIO$5M

Enterprise Value

LNAI$3M

XBIO$-2M

Price

LNAI$1.23

XBIO$2.13

P/E Ratio

LNAIN/A

XBION/A

P/S Ratio

LNAI266.60x

XBIO1.50x

EV/Sales

LNAI163.08x

XBIO-0.49x

EV/EBITDA

LNAI0.00x

XBIO0.00x

P/B Ratio

LNAI0.07x

XBIO0.81x

P/FCF Ratio

LNAIN/A

XBION/A

EV/FCF

LNAI-0.65x

XBIO0.69x

PEG Ratio

LNAIN/A

XBION/A

Forward P/E (NTM)

LNAIN/A

XBION/A

Forward P/S (NTM)

LNAIN/A

XBION/A

Revenue (TTM)

LNAI$21K

XBIO$3M

Revenue Growth (YoY)

LNAIN/A

XBIO33.3%

Forward Rev Growth

LNAI0.0%

XBIO-16.7%

Gross Margin (TTM)

LNAI0.0%

XBIO98.7%

Operating Margin (TTM)

LNAI0.0%

XBIO0.0%

EBITDA Margin (TTM)

LNAI-46584.2%

XBIO-81.0%

Net Margin (TTM)

LNAI-613799.0%

XBIO-75.9%

FCF Margin (TTM)

LNAI-25165.1%

XBIO-70.9%

Net Income (TTM)

LNAI$-128M

XBIO$-2M

FCF (TTM)

LNAI$-5M

XBIO$-2M

EPS (TTM)

LNAI-$41.06

XBIO-$1.08

ROE (TTM)

LNAI-6700.0%

XBIO-4062.0%

ROA (TTM)

LNAI-161778.0%

XBIO-3497.0%

ROIC (TTM)

LNAI-6439.0%

XBIO-4062.0%

Cash

LNAI$3M

XBIO$6M

Debt

LNAI$992K

XBIO$0

Net Cash/Debt

LNAI$2M

XBIO$6M

Current Ratio (TTM)

LNAI0.19x

XBIO7.43x

Quick Ratio (TTM)

LNAI0.16x

XBIO7.23x

Debt/Equity (TTM)

LNAI0.07x

XBIO0.00x

Debt/Assets (TTM)

LNAI0.0%

XBIO0.0%

Interest Coverage (TTM)

LNAIN/A

XBION/A

Net Debt/EBITDA (TTM)

LNAI0.00x

XBIO0.00x

Beta

LNAI0.32

XBIO2.36

52W Performance

LNAI-87.6%

XBIO-79.4%

YTD Performance

LNAI-84.2%

XBIO-0.9%

% from 52W High

LNAI-90.7%

XBIO-79.2%

% from 52W Low

LNAI40.5%

XBIO13.9%

Asset Turnover (TTM)

LNAI0.00x

XBIO0.46x

FCF Yield (TTM)

LNAI-94.4%

XBIO-47.4%

Earnings Yield (TTM)

LNAI-2302.3%

XBIO-50.7%

Dividend Yield (TTM)

LNAIN/A

XBION/A

Rule of 40

LNAI-25,165.1

XBIO-37.6

EV/GP/RG

LNAIN/A

XBION/A

Ticker research

View LNAI research View XBIO research

Metric	LNAI Lunai Bioworks Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$6M	$5M
Enterprise Value	$3M	$-2M
Price	$1.23	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	266.60x	1.50x
EV/Sales	163.08x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.07x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$21K	$3M
Revenue Growth (YoY)	N/A	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	0.0%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-46584.2%	-81.0%
Net Margin (TTM)	-613799.0%	-75.9%
FCF Margin (TTM)	-25165.1%	-70.9%
Net Income (TTM)	$-128M	$-2M
FCF (TTM)	$-5M	$-2M
EPS (TTM)	-$41.06	-$1.08
ROE (TTM)	-6700.0%	-4062.0%
ROA (TTM)	-161778.0%	-3497.0%
ROIC (TTM)	-6439.0%	-4062.0%
Financial Health
Cash	$3M	$6M
Debt	$992K	$0
Net Cash/Debt	$2M	$6M
Current Ratio (TTM)	0.19x	7.43x
Quick Ratio (TTM)	0.16x	7.23x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.32	2.36
52W Performance	-87.6%	-79.4%
YTD Performance	-84.2%	-0.9%
% from 52W High	-90.7%	-79.2%
% from 52W Low	40.5%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.46x
FCF Yield (TTM)	-94.4%	-47.4%
Earnings Yield (TTM)	-2302.3%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-25,165.1	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View LNAI research	View XBIO research